These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2454367)

  • 1. Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
    Bartsch W; Sponer G; Strein K; Böhm E; Hooper RG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S49-51. PubMed ID: 2454367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mode of vasodilating action of carvedilol.
    Sponer G; Strein K; Müller-Beckmann B; Bartsch W
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S42-8. PubMed ID: 2454366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonists.
    Park KH; Long JP; Cannon JG
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1221-30. PubMed ID: 1762069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
    Hashimoto H; Tanaka M; Kanda A; Akashi A
    Drugs; 1988; 36 Suppl 6():31-6. PubMed ID: 2908302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postural hypotension in elderly patients given carvedilol.
    Krum H; Conway EL; Broadbear JH; Howes LG; Louis WJ
    BMJ; 1994 Sep; 309(6957):775-6. PubMed ID: 7950564
    [No Abstract]   [Full Text] [Related]  

  • 6. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
    Hashimoto H; Kanda A; Hubo H; Tanaka M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for evaluating postural hypotension in conscious rabbits as a model to predict effects of drugs in man.
    Sponer G; Mannesmann G; Bartsch W; Dietmann K
    J Pharmacol Methods; 1981 Jan; 5(1):53-8. PubMed ID: 7265985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with dual-acting drugs in hypertension.
    Rahn KH
    Clin Investig; 1992; 70 Suppl 1():S39-42. PubMed ID: 1350483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. omega-Conotoxin GVIA and prazosin, but not felodipine, cause postural hypotension in rabbits.
    Hawkes AL; Angus JA; Wright CE
    Clin Exp Pharmacol Physiol; 1995 Oct; 22(10):711-6. PubMed ID: 8575106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R
    Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of carvedilol, a compound with beta-blocking and vasodilating properties.
    Strein K; Sponer G; Müller-Beckmann B; Bartsch W
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S33-41. PubMed ID: 2454365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
    Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S81-4. PubMed ID: 2454374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive compounds with combined actions.
    Rahn KH
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S18-22. PubMed ID: 2454363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rabbit model for evaluation of chlorpromazine-induced orthostatic hypotension.
    Takata Y; Kurihara J; Suzuki S; Okubo Y; Kato H
    Biol Pharm Bull; 1999 May; 22(5):457-62. PubMed ID: 10375164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of carvedilol in normal volunteers.
    Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
    Clin Pharmacol Ther; 1987 Jan; 41(1):31-44. PubMed ID: 3802704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
    Strein K; Sponer G
    Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-human primate model for investigating drug-induced risk of orthostatic hypotension and sympathetic dysfunction: Preclinical correlate to a clinical test.
    Bhatt S; Foote S; Smith A; Butler P; Steidl-Nichols J
    J Pharmacol Toxicol Methods; 2015; 73():49-55. PubMed ID: 25837852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model of orthostatic hypotension in the conscious monkey using lower body negative pressure.
    Murphy DJ; Renninger JP; Ju H
    J Pharmacol Toxicol Methods; 2006; 54(2):106-15. PubMed ID: 16650782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.